- Citations, last 5 years
- 139
- Works, last 5 years
- 72
- h-index
- 40
- Scientists listed
- 12
- Grants since 2016
- 829
Grants received
2019–2024 · research · R01
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
Timothy Yikai Huang · Discovery Institute · funded by National Institutes of Health
2019–2024 · research · R01
Denervation activated super-enhancers of pathogenic IL6-STAT3 feedforward loop in FAPs
Pier Lorenzo Puri · Discovery Institute · funded by National Institutes of Health
2019–2024 · research · R01
Brain pathology and function in a chronic mouse model of ZIKV transmission
Alysson R. Muotri · Discovery Institute · funded by National Institutes of Health
2019–2024 · research · R01
Targeting neuroinflammation in AD with novel CX3CR1 agonists
Kevin Ron Nash · Discovery Institute · funded by National Institutes of Health
2019–2023 · research · R01
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
Nicholas F. Larusso · Discovery Institute · funded by National Institutes of Health
2019–2027 · research · R01
Eph Receptor Heterointeractions in Signaling
Kalina Hristova · Discovery Institute · funded by National Institutes of Health
2019–2023 · research · R01
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
Timothy Yikai Huang · Discovery Institute · funded by National Institutes of Health
2019–2022 · fellowship · F32
Role of HDAC7 in senescence-associated inflammation
Karl Nathan Miller · Discovery Institute · funded by National Institutes of Health
2019–2022 · research · R01
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
Douglas J Sheffler · Discovery Institute · funded by National Institutes of Health
2019–2023 · research · R01
Ligand functional selectivity in EphA2 receptor signaling
Kalina Hristova · Discovery Institute · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing the nuclear pore complex-T cell receptor connection
Maximiliano A Dangelo · Discovery Institute · funded by National Institutes of Health
2019–2022 · research · R01
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
Douglas J Sheffler · Discovery Institute · funded by National Institutes of Health
2019–2023 · research · R01
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
Nicholas F. Larusso · Discovery Institute · funded by National Institutes of Health
2019–2022 · research · R01
Ligand functional selectivity in EphA2 receptor signaling
Kalina Hristova · Discovery Institute · funded by National Institutes of Health
2019–2025 · research · R01
Characterizing the nuclear pore complex-T cell receptor connection
Maximiliano A Dangelo · Discovery Institute · funded by National Institutes of Health
2019–2022 · research · R21
Nuclear pore regulation of leukemia cell metabolism and survival
Marcela Raices · Discovery Institute · funded by National Institutes of Health
2019–2027 · research · R01
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
Michael Karin · Discovery Institute · funded by National Institutes of Health
2019–2027 · research · R01
Eph Receptor Heterointeractions in Signaling
Kalina Hristova · Discovery Institute · funded by National Institutes of Health
2019–2027 · research · R01
Eph Receptor Heterointeractions in Signaling
Kalina Hristova · Discovery Institute · funded by National Institutes of Health
2018–2020 · research · R21
A Novel Conformation of the ZIKV Protease Provides a Unique 3D Scaffold for Discovering Allosteric Protease Inhibitors as Direct Anti-virals, via HT and Virtual Screening, and Protein Engineering
Sumit K Chanda · Discovery Institute · funded by National Institutes of Health
2018–2022 · research · R01
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
Sumit K Chanda · Discovery Institute · funded by National Institutes of Health
2018–2021 · research · R01
Inhibiting Multi-Functional ALDOA for Cancer Therapy
Garth Powis · Discovery Institute · funded by National Institutes of Health
2018–2019 · research · R21
CD44 Promotes Chronic Virus Infection
Linda Mac Pherson Bradley · Discovery Institute · funded by National Institutes of Health
2018–2019 · research · R21
CD44 Promotes Chronic Virus Infection
Linda Mac Pherson Bradley · Discovery Institute · funded by National Institutes of Health
2018 · research · R01
Identification of Hypoxia-Inducible Factor-2alpha Activators for Chronic Kidney Disease Anemia
Fraydoon Rastinejad · Discovery Institute · funded by National Institutes of Health
2018–2023 · research · R01
S1P signaling machinery in neuroimmune interactions
Yasuyuki Kihara · Discovery Institute · funded by National Institutes of Health
2018–2023 · research · R01
High Throughput Screen to Discover Modulators of TREM2 Activity
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2018–2021 · research · R01
High Throughput Screen to Discover Modulators of TREM2 Activity
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2018–2021 · research · R01
High Throughput Screen to Discover Modulators of TREM2 Activity
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2018–2023 · research · R01
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD
Timothy Yikai Huang · Discovery Institute · funded by National Institutes of Health
2018–2022 · research · R01
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
Sumit K Chanda · Discovery Institute · funded by National Institutes of Health
2018–2023 · training · T32
Cancer Targets and Drug Discovery
Nicholas David Cosford · Discovery Institute · funded by National Institutes of Health
2018–2023 · research · R01
S1P signaling machinery in neuroimmune interactions
Yasuyuki Kihara · Discovery Institute · funded by National Institutes of Health
2018–2023 · research · R01
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in AD
Timothy Yikai Huang · Discovery Institute · funded by National Institutes of Health
2018–2021 · career development · K22
A pan-cancer role for MutL loss in inducing treatment resistance
Svasti Haricharan · Discovery Institute · funded by National Institutes of Health
2018–2023 · training · T32
Cancer Targets and Drug Discovery
Nicholas David Cosford · Discovery Institute · funded by National Institutes of Health
2018–2023 · training · T32
Cancer Targets and Drug Discovery
Garth Powis · Discovery Institute · funded by National Institutes of Health
2018–2023 · training · T32
Frontiers in Fundamental and Translational Immunology
Linda Mac Pherson Bradley · Discovery Institute · funded by National Institutes of Health
2018–2020 · research · R21
A Novel Conformation of the ZIKV Protease Provides a Unique 3D Scaffold for Discovering Allosteric Protease Inhibitors as Direct Anti-virals, via HT and Virtual Screening, and Protein Engineering
Robert Colin Liddington · Discovery Institute · funded by National Institutes of Health
2018 · cooperative agreement · UG3
Electrical Stimulation of Human Myocytes in Microgravity: An In Vitro Model to Evaluate Therapeutics to Counteract Muscle Wasting
Siobhan Malany · Discovery Institute · funded by National Institutes of Health